Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
15
CLNN Quote, Financials, Valuation and Earnings
Last price:
$5.71
Seasonality move
:
-1.03%
Day range:
$5.66 - $6.55
52-week range:
$2.28 - $13.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
247.53x
P/B ratio:
13.16x
Volume:
425.5K
Avg. volume:
260.8K
1-year change:
38.7%
Market cap:
$51.8M
Revenue:
$342K
EPS (TTM):
-$3.39
Analysts' Opinion
-
Consensus RatingClene, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $31.86, Clene, Inc. has an estimated upside of 452.12% from its current price of $5.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.00 representing -298.61% downside risk from its current price of $5.77.
Fair Value
-
According to the consensus of 6 analysts, Clene, Inc. has 452.12% upside to fair value with a price target of $31.86 per share.
CLNN vs. S&P 500
-
Over the past 5 trading days, Clene, Inc. has underperformed the S&P 500 by -44.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Clene, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Clene, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Clene, Inc. reported revenues of $15K.
Earnings Growth
-
Clene, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Clene, Inc. reported earnings per share of -$0.85.
Enterprise value:
65.2M
EV / Invested capital:
7.28x
Price / LTM sales:
247.53x
EV / EBIT:
--
EV / Revenue:
304.75x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1.4M
Return On Assets:
-118.52%
Net Income Margin (TTM):
-14250.47%
Return On Equity:
-4726.49%
Return On Invested Capital:
-224.36%
Operating Margin:
-37653.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $718K | $421K | $214K | $87K | $15K | |
| Gross Profit | -$1.4M | -$1.3M | -$1.4M | -$337K | -$350K | |
| Operating Income | -$42.3M | -$34.4M | -$24.2M | -$7.8M | -$5.6M | |
| EBITDA | -$40.3M | -$32.7M | -$22.7M | -$7.4M | -$5.3M | |
| Diluted EPS | -$0.48 | -$0.28 | -$3.39 | -$0.06 | -$0.85 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $65.4M | $21.5M | $46.4M | $19.7M | $12.7M | |
| Total Assets | $73M | $36M | $60.4M | $31.6M | $22.3M | |
| Current Liabilities | $4.8M | $6.2M | $15.3M | $23.8M | $8.3M | |
| Total Liabilities | $67.4M | $45.3M | $39M | $35.7M | $34.7M | |
| Total Equity | $5.7M | -$9.3M | $21.4M | -$4.1M | -$12.4M | |
| Total Debt | $23.8M | $26.3M | $31.4M | $22.1M | $20.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$30.8M | -$23.7M | -$18.6M | -$3M | -$4M | |
| Cash From Investing | $7M | $110.5K | -$300 | $8.2K | -$11K | |
| Cash From Financing | $58.6M | -$4M | $12M | -$4.1M | $4.6M | |
| Free Cash Flow | -$32.8M | -$23.8M | -$18.6M | -$3M | -$4M | |
CLNN
Sector
Market Cap
$51.8M
$28.5M
Price % of 52-Week High
42.74%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-17.34%
-1.33%
1-Year Price Total Return
38.7%
-20.32%
Beta (5-Year)
0.787
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.51
200-day SMA
Buy
Level
$5.22
Bollinger Bands (100)
Sell
Level
4.49 - 9.23
Chaikin Money Flow
Sell
Level
-2.5M
20-day SMA
Sell
Level
$8.78
Relative Strength Index (RSI14)
Sell
Level
32.53
ADX Line
Sell
Level
20.48
Williams %R
Buy
Level
-97.8764
50-day SMA
Sell
Level
$8.84
MACD (12, 26)
Sell
Level
-0.43
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Sell
Level
-3.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-17.461)
Sell
CA Score
(Annual)
Level (-6.2417)
Buy
Beneish M-Score
(Annual)
Level (-6.075)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (11.2241)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Stock Forecast FAQ
In the current month, CLNN has received 6 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CLNN average analyst price target in the past 3 months is $31.86.
-
Where Will Clene, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Clene, Inc. share price will rise to $31.86 per share over the next 12 months.
-
What Do Analysts Say About Clene, Inc.?
Analysts are divided on their view about Clene, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Clene, Inc. is a Sell and believe this share price will drop from its current level to $23.00.
-
What Is Clene, Inc.'s Price Target?
The price target for Clene, Inc. over the next 1-year time period is forecast to be $31.86 according to 6 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CLNN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Clene, Inc. is a Buy. 6 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CLNN?
You can purchase shares of Clene, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Clene, Inc. shares.
-
What Is The Clene, Inc. Share Price Today?
Clene, Inc. was last trading at $5.71 per share. This represents the most recent stock quote for Clene, Inc.. Yesterday, Clene, Inc. closed at $5.77 per share.
-
How To Buy Clene, Inc. Stock Online?
In order to purchase Clene, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CLNN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLNN
Sector
P/E ratio
--
23.75x
PEG ratio
0.00x
-0.01x
P/B ratio
13.16x
1.83x
Price / LTM sales
247.53x
1.60x
Growth Metrics
CLNN
Sector
Revenue growth
-82.76%
4.85%
Earnings growth
-1301.31%
11.11%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.56
-$0.20
Profitability
CLNN
Sector
Profitability FY 2024
-$1.4M
$3.6M
Return on invested capital
-224.36%
-30.98%
Return on assets
-118.52%
-27.62%
Return on equity
-4726.49%
-36.69%
Earnings Date
Last Earnings Date
Aug
13
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
CLNN
Sector
Total cash
$7.9M
$27.2M
Short term investments
--
$25.7M
Total assets
$27.3M
$79.7M
Long term debt
$20.5M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
